Find your elected official's email information HERE.
Open your preferred email account and start a new draft.
Copy and paste the below email template. CC our BEF Team-member Meredith Marden at mmarden@esiason.org
Hit SEND! You've done your part.
PASTEUR Act
Subject: Support the PASTEUR Act to Defend Against Antimicrobial Resistance!
As a concerned constituent and as an advocate of the cystic fibrosis (CF) community, I urge you to support the passage of the PASTEUR Act (H.R. 2940/S. 1355) to combat the growing threat of antimicrobial resistance (AMR). AMR is a rapidly evolving danger to the American public and disproportionately affects people living with CF. People with CF require treatment with antimicrobial medicines from a young age to fight recurring lung infections, so they are at a greater risk of their infections becoming increasingly resistant over time, leading to end-stage disease and complicating transplant eligibility.
The PASTEUR Act is a proposed bipartisan, bicameral legislation that would address the current lack of an effective pipeline for antimicrobials by spurring investment in novel antimicrobial development. This act supports a subscription-style model that ensures that innovators have a sustainable financial incentive and path to profitability, thus removing a significant barrier to antimicrobial development. The PASTEUR Act not only funds the production of new antimicrobials, but also creates diagnostic tools, surveillance systems, vaccines, and other alternative treatments to ensure that new medicines are quickly generated and used safely and effectively.
To protect the lives of people living with CF and all those whose lives are threatened by AMR, I urge you to act now and quickly pass the PASTEUR Act.
HELP Copays Act
Subject: Support the HELP Copays Act to Protect Critical Patient Assistance!
As a concerned constituent and as an advocate of the cystic fibrosis (CF) community, I urge you to support the passage of the The Help Ensure Lower Patient Copays (HELP) Copays Act (S.864) to protect patients from copay adjustment programs, including accumulators and maximizers. Copay accumulator programs used by insurers and pharmacy benefit managers (PBMs) siphon copay assistance away from patients by not counting third-party assistance towards cost-sharing requirements such as deductibles and out-of-pocket (OOP) maximums.
The HELP Copays Act restricts the use of these programs by including any third-party assistance toward patients’ individual and family cost-sharing requirements. The act also closes the loophole that allows insurers and PBMs to deem a product “non-essential,” which avoids annually set OOP maximums.
The HELP Copays Act would protect patients from copay adjustment programs and allow copay assistance to work as intended– to make prescription drugs affordable for patients. Copay assistance is critical for patients who rely on brand-name drugs without generic alternatives. Copay adjustment programs, while designed to prevent overutilization, are not transparent and can levy financial pain against often unknowing victims. They must be removed from the health insurance marketplace through the HELP Copays Act.